High density lipoprotein protects mesenchymal stem cells from oxidative stress-induced apoptosis via activation of the PI3K/Akt pathway and suppression of reactive oxygen species

International Journal of Molecular Sciences

Volumn 13, Issue 12, 2012, Pages 17104-17120

  Xu, Jianfeng ^a,b   Qian, Juying ^a   Xie, Xinxing ^a   Lin, Li ^a   Zou, Yunzeng ^a   Fu, Mingqiang ^a   Huang, Zheyong ^a   Zhang, Guoping ^a   Su, Yangang ^a   Ge, Junbo ^a  

^a FUDAN UNIVERSITY   (China)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Apoptosis; High density lipoprotein; Mesenchymal stem cells; Myocardial infarction; Oxidative stress

Indexed keywords

BETA GALACTOSIDASE; BETA1 INTEGRIN; CASPASE 3; CD34 ANTIGEN; CD45 ANTIGEN; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; HIGH DENSITY LIPOPROTEIN; HYDROGEN PEROXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; REACTIVE OXYGEN METABOLITE; THY 1 ANTIGEN; OXIDIZING AGENT;

ANIMAL CELL; ANIMAL TISSUE; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL SURVIVAL; CELL VIABILITY; CHEMOLUMINESCENCE; CONTROLLED STUDY; DENSITOMETRY; DNA PURIFICATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME REPRESSION; HEART FUNCTION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; ISCHEMIC PRECONDITIONING; MESENCHYMAL STEM CELL; NONHUMAN; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SURVIVAL RATE; UPREGULATION; ANIMAL; CYTOLOGY; DRUG EFFECTS; MESENCHYMAL STROMA CELL; METABOLISM; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; APOPTOSIS; HYDROGEN PEROXIDE; LIPOPROTEINS, HDL; MESENCHYMAL STROMAL CELLS; OXIDANTS; OXIDATIVE STRESS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION;

EID: 84871704051     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms131217104     Document Type: Article

References (29)

1. Huang, J.; Zhang, Z.; Guo, J.; Ni, A.; Deb, A.; Zhang, L.; Mirotsou, M.; Pratt, R.E.; Dzau, V.J. Genetic Modification of Mesenchymal Stem Cells Overexpressing CCR1 Increases Cell Viability, Migration, Engraftment, and Capillary Density in the Injured Myocardium. Circ. Res. 2010, 106, 1753-1762.
2. Wen, Z.Z.; Zheng, S.X.; Zhou, C.Q.; Yuan, W.L.; Wang, J.F.; Wang, T. Bone marrow mesenchymal stem cells for post-myocardial infarction cardiac repair: MicroRNAs as novel regulators. J. Cell. Mol. Med. 2012, 16, 657-671.
3. Luo, Y.; Wang, Y.; Poynter, J.A.; Manukyan, M.C.; Herrmann, J.L.; Abarbanell, A.M.; Weil, B.R.; Meldrum, D.R. Pretreating mesenchymal stem cells with interleukin-1 beta and transforming growth factor-beta synergistically increases vascular endothelial growth factor production and improves mesenchymal stem cell-mediated myocardial protection after acute ischemia. Surgery 2012, 151, 353-363.
4. Wei, H.; Li, Z.; Hu, S.; Chen, X.; Cong, X. Apoptosis of Mesenchymal Stem Cells Induced by Hydrogen Peroxide Concerns Both Endoplasmic Reticulum Stress and Mitochondrial Death Pathway Through Regulation of Calspases, p38 and JNK. J. Cell. Biochem. 2010, 111, 967-978.
5. Wang, X.; Zhao, T.; Huang, W.; Wang, T.; Qian, J.; Xu, M.; Kranias, E.G.; Wang, Y.; Fan, G.-C. Hsp20-Engineered Mesenchymal Stem Cells Are Resistant to Oxidative Stress via Enhanced Activation of Akt and Increased Secretion of Growth Factors. Stem Cells 2009, 27, 3021-3031.
6. Zanichelli, F.; Capasso, S.; di Bernardo, G.; Cipollaro, M.; Pagnotta, E.; Carteni, M.; Casale, F.; Iori, R.; Giordano, A.; Galderisi, U. Low concentrations of isothiocyanates protect mesenchymal stem cells from oxidative injuries, while high concentrations exacerbate DNA damage. Apoptosis 2012, 17, 964-974.
7. Duffy, D.; Holmes, D.N.; Roe, M.T.; Peterson, E.D. The impact of high-density lipoprotein cholesterol levels on long-term outcomes after non-ST-elevation myocardial infarction. Am. Heart J. 2012, 163, 705-713.
8. Navab, M.; Reddy, S.T.; van Lenten, B.J.; Fogelman, A.M. HDL and cardiovascular disease: Atherogenic and atheroprotective mechanisms. Nat. Rev. Cardiol. 2011, 8, 222-232.
9. Lin, L.; Gong, H.; Ge, J.; Jiang, G.; Zhou, N.; Li, L.; Ye, Y.; Zhang, G.; Ge, J.; Zou, Y. High density lipoprotein downregulates angiotensin II type 1 receptor and inhibits angiotensin II-induced cardiac hypertrophy. Biochem. Biophys. Res. Commun. 2011, 404, 28-33.
10. Nicholls, S.J.; Dusting, G.J.; Cutri, B.; Bao, S.; Drummond, G.R.; Rye, K.A.; Barter, P.J. Reconstituted high-density lipoproteins inhibit the acute pro-oxidant and proinflammatory vascular changes induced by a periarterial collar in normocholesterolemic rabbits. Circulation 2005, 111, 1543-1550.
11. De Souza, J.A.; Vindis, C.; Negre-Salvayre, A.; Rye, K.-A.; Couturier, M.; Therond, P.; Chantepie, S.; Salvayre, R.; Chapman, M.J.; Kontush, A. Small, dense HDL 3 particles attenuate apoptosis in endothelial cells: pivotal role of apolipoprotein A-I. J. Cell. Mol. Med. 2010, 14, 608-620.
12. Sumi, M.; Sata, M.; Miura, S.-I.; Rye, K.-A.; Toya, N.; Kanaoka, Y.; Yanaga, K.; Ohki, T.; Saku, K.; Nagai, R. Reconstituted high-density lipoprotein stimulates differentiation of endothelial progenitor cells and enhances ischemia-induced angiogenesis. Arterioscler. Thromb. Vasc. Biol. 2007, 27, 813-818.
13. Ng, K.-M.; Lee, Y.-K.; Lai, W.-H.; Chan, Y.-C.; Fung, M.-L.; Tse, H.-F.; Siu, C.-W. Exogenous Expression of Human apoA-I Enhances Cardiac Differentiation of Pluripotent Stem Cells. PLoS One 2011, 6, e19787.
14. Yvan-Charvet, L.; Pagler, T.; Gautier, E.L.; Avagyan, S.; Siry, R.L.; Han, S.; Welch, C.L.; Wang, N.; Randolph, G.J.; Snoeck, H.W.; et al. ATP-Binding Cassette Transporters and HDL Suppress Hematopoietic Stem Cell Proliferation. Science 2010, 328, 1689-1693.
15. Wang, B.; Shravah, J.; Luo, H.; Raedschelders, K.; Chen, D.D.Y.; Ansley, D.M. Propofol protects against hydrogen peroxide-induced injury in cardiac H9c2 cells via Akt activation and Bcl-2 up-regulation. Biochem. Biophys. Res. Commun. 2009, 389, 105-111.
16. Brandl, A.; Meyer, M.; Bechmann, V.; Nerlich, M.; Angele, P. Oxidative stress induces senescence in human mesenchymal stem cells. Exp. Cell. Res. 2011, 317, 1541-1547.
17. Di Bernardo, G.; Alessio, N.; Dell'Aversana, C.; Casale, F.; Teti, D.; Cipollaro, M.; Altucci, L.; Galderisi, U. Impact of Histone Deacetylase Inhibitors SAHA and MS-275 on DNA Repair Pathways in Human Mesenchymal Stem Cells. J. Cell. Physiol. 2010, 225, 537-544.
18. Zhu, Z.; Sun, H.; Ma, G.; Wang, Z.; Li, E.; Liu, Y.; Liu, Y. Bufalin Induces Lung Cancer Cell Apoptosis via the Inhibition of PI3K/Akt Pathway. Int. J. Mol. Sci. 2012, 13, 2025-2035.
19. Li, S.; Bian, H.; Liu, Z.; Wang, Y.; Dai, J.; He, W.; Liao, X.; Liu, R.; Luo, J. Chlorogenic acid protects MSCs against oxidative stress by altering FOXO family genes and activating intrinsic pathway. Eur. J. Pharmacol. 2012, 674, 65-72.
20. Tam, D.N.N.; Son, Y.O.; Lim, S.S.; Shi, X.L.; Kim, J.G.; Heo, J.S.; Choe, Y.; Jeon, Y.M.; Lee, J.C. Sodium fluoride induces apoptosis in mouse embryonic stem cells through ROS-dependent and caspase-and JNK-mediated pathways. Toxicol. Appl. Pharmacol. 2012, 259, 329-337.
21. Kiya, Y.; Miura, S.-I.; Imaizumi, S.; Uehara, Y.; Matsuo, Y.; Abe, S.; Jimi, S.; Urata, H.; Rye, K.-A.; Saku, K. Reconstituted high-density lipoprotein attenuates postinfarction left ventricular remodeling in rats. Atherosclerosis 2009, 203, 137-144.
22. Xie, X.X.; Sun, A.J.; Zhu, W.Q.; Huang, Z.Y.; Hu, X.Y.; Jia, J.G.; Zou, Y.Z.; Ge, J.B. Transplantation of Mesenchymal Stem Cells Preconditioned with Hydrogen Sulfide Enhances Repair of Myocardial Infarction in Rats. Tohoku J. Exp. Med. 2012, 226, 29-36.
23. Mangi, A.A.; Noiseux, N.; Kong, D.L.; He, H.M.; Rezvani, M.; Ingwall, J.S.; Dzau, V.J. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat. Med. 2003, 9, 1195-1201.
24. Suzuki, Y.; Kim, H.W.; Ashraf, M.; Haider, H.K. Diazoxide potentiates mesenchymal stem cell survival via NF-κ B-dependent miR-146a expression by targeting Fas. Am. J. Physiol. Heart Circul. Physiol. 2010, 299, H1077-H1082.
25. Rossoni, G.; Gomaraschi, M.; Berti, F.; Sirtori, C.R.; Franceschini, G.; Calabresi, L. Synthetic high-density lipoproteins exert cardioprotective effects in myocardial ischemia/reperfusion injury. J. Pharmacol. Exp. Ther. 2004, 308, 79-84.
26. Strandberg, T.E.; Saijonmaa, O.; Fyhrquist, F.; Tilvis, R.S.; Strandberg, A.Y.; Miettinen, T.A.; Pitkala, K.H.; Salomaa, V. Telomere length in old age and cholesterol across the life course. J. Am. Geriatr. Soc. 2011, 59, 1979-1981.
27. Barzilai, N.; Atzmon, G.; Schechter, C.; Schaefer, E.J.; Cupples, A.L.; Lipton, R.; Cheng, S.; Shuldiner, A.R. Unique lipoprotein phenotype and genotype associated with exceptional longevity. J. Am. Med. Assoc. 2003, 290, 2030-2040.
28. Tian, L.; Fu, M. The relationship between high density lipoprotein subclass profile and apolipoprotein concentrations. J. Endocrinol. Invest. 2011, 34, 461-472.
29. Terasaka, N.; Wang, N.; Yvan-Charvet, L.; Tall, A.R. High-density lipoprotein protects macrophages from oxidized low-density lipoprotein-induced apoptosis by promoting efflux of 7-ketocholesterol via ABCG1. Proc. Natl. Acad. Sci. USA 2007, 104, 15093-15098.